DNA Repair Drugs: The past or future of cancer treatment, Market Growth to register a CAGR of 32.4% to reach US$ 8,378.1 Million by 2027

Global DNA Repair Drugs Market Analysis

Overview

DNA repair medications are used to cure tumors and to repair damaged DNA. Genetic abnormalities are caused by DNA disruption, but the human body has its own mechanisms for correcting the DNA chain. PARP inhibitors and other DNA repair medications are used to cure disorders caused by genetic abnormalities.

The global DNA repair drugs market was worth US$ 461.3 million in 2017, and it is projected to develop at a 32.4 percent CAGR from 2018 to 2026.

Get Sample PDF Including COVID-19 Impact Analysis: https://www.coherentmarketinsights.com/insight/request-pdf/2617

Drivers

The global DNA repair drugs market is expected to rise due to increasing cancer incidence, growing government measures to raise cancer care visibility, and manufacturers' expansion strategies to increase and extend their product range in foreign markets.

Over the forecast period, the global DNA repair drugs market is expected to rise due to an increase in cancer rates. Breast cancer accounted for the second largest number of cancer deaths (2,088,849 new cases) worldwide in 2018, according to a survey published by the World Cancer Research Fund International. According to GLOBOCAN, new cases of breast cancer increased by 43.6 percent in Asia Pacific in 2018.

Furthermore, rising drug approval by key players to meet demand for effective therapeutics is projected to drive market growth over the forecast period. Talazoparib (Talzenna) was approved by the US Food and Drug Administration (FDA) in October 2018 for the treatment of HER2 positive patients (negative locally advanced or metastatic breast cancer).

Delays in regulatory approvals, on the other hand, trigger a pause in product marketing, which can have a negative impact on the manufacturer's sales production. Delays in post-approval of a prescription product for another medicinal indication, on the other hand, increase clinical trial costs and may have an effect on the branding and clearance status of commercially approved drugs.

Tailored Information as per niche requirement:

LIMITED TIME OFFER - Hurry Up!

Exclusive offer!!! Purchase the report at a discounted rate!!!

Get Discount For Buyers UPTO 30% OFF On Any Research Report

Buy Now with Discount for Premium Report 2021: https://www.coherentmarketinsights.com/promo/buynow/2617

The market is projected to expand due to the rising incidence of cancer, as well as increased partnerships and alliances by main players.

Regional Insights

Due to the rising prevalence of cancer, North America is estimated to dominate the global DNA repair drugs market over the forecast period. As per the American Cancer Society, 266,120 new cases of advanced breast cancer were diagnosed in the U.S. in 2018. Furthermore, rising demand for cancer therapies is expected to propel the market for DNA repair drugs in the region.

To meet the growing demand for DNA repair products, market players are investing in research and development. Clovis Oncology, Inc., Bristol-Myers Squibb Company, and Foundation Medicine Inc. partnered in May 2019 to start a phase II trial assessing rucaparib in conjunction with nivolumab in patients with HGSC or endometroid ovarian cancer.

View Press Release For More Information @ https://www.coherentmarketinsights.com/press-release/dna-repair-drugs-market-to-surpass-us-83781-million-by-2026-2455

Key Players

Key companies contributing in the global DNA repair drugs market include Merck KGaA, Bristol - Myers Squibb, Clovis Oncology Inc., GlaxoSmithKline plc., Karyopharm Therapeutics Inc., AstraZeneca Plc., Jiangsu Hengrui Medicine Co., Ltd., Johnson & Johnson, Ono Pharmaceutical Co., Ltd., Pfizer, Inc., AbbVie Inc., Repare Therapeutics Inc., and Genentech, Inc.

Table of Contents

1. Research Objectives and Assumptions
• Research Objectives
• Assumptions
• Abbreviations
2. Market Purview
• Report Description
• Market Definition and Scope
• Executive Summary
• Market Snippet, By Drug Type
• Market Snippet, By Application
• Market Snippet, By Distribution Channel
• Market Snippet, By Region
• Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
• Market Dynamics
• Drivers
• Restraints
• Market Opportunities
• Impact Analysis
• Pipeline Analysis
• Regulatory Scenario
• Pricing Analysis
• PEST Analysis
• Epidemiology
4. Global DNA Repair Drugs Market, By Drug Type, 2018 – 2026, (US$ Mn)
• Introduction
• Market Share Analysis, 2018 and 2026 (%)
• Y-o-Y Growth Analysis, 2017 – 2026
• Segment Trends
• Niraparib (Zejula)
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
• Olaparib (Lynparza)
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
• Rucaparib (Rubraca)
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
• Talazoparib (Talzenna)
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
5. Global DNA Repair Drugs Market, By Application, 2018 – 2026, (US$ Mn)
• Introduction
• Market Share Analysis, 2018 and 2026 (%)
• Y-o-Y Growth Analysis, 2017 – 2026
• Segment Trends
• Ovarian Cancer
•  Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
• Breast Cancer
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
6. Global DNA Repair Drugs Market , By Distribution Channel, 2018 – 2026, (US$ Mn)
• Introduction
• Market Share Analysis, 2018 and 2026 (%)
• Y-o-Y Growth Analysis, 2017 – 2026
• Segment Trends
• Hospital Pharmacies
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
• Retail Pharmacies
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
• Online Pharmacies
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
7. Global DNA Repair Drugs Market , By Region, 2018 – 2026, (US$ Mn)
• Introduction
• Market Share Analysis, By Region, 2018 and 2026 (%)
• Y-o-Y Growth Analysis, For Regions, 2017–2026
• North America
• Market Size and Forecast, By Drug Type, 2016 – 2026, (US$ Mn)
• Market Size and Forecast, By Application, 2016 – 2026, (US$ Mn)
• Market Size and Forecast, By Distribution Channel, 2016 – 2026, (US$ Mn)
• Market Size and Forecast, By Country, 2016 – 2026, (US$ Mn)
• U.S.
• Canada
• Latin America
• Market Size and Forecast, By Drug Type, 2016 – 2026, (US$ Mn)
• Market Size and Forecast, By Application, 2016 – 2026, (US$ Mn)
• Market Size and Forecast, By Distribution Channel, 2016 – 2026, (US$ Mn)
• Market Size and Forecast, By Country, 2016 – 2026, (US$ Mn)
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Europe
• Market Size and Forecast, By Drug Type, 2016 – 2026, (US$ Mn)
• Market Size and Forecast, By Application, 2016 – 2026, (US$ Mn)
• Market Size and Forecast, By Distribution Channel, 2016 – 2026, (US$ Mn)
• Market Size and Forecast, By Country, 2016 – 2026, (US$ Mn)
• Germany
• U.K.
• France
• Italy
• Spain
• Russia
• Rest of Europe
• Asia Pacific
• Market Size and Forecast, By Drug Type, 2016 – 2026, (US$ Mn)
• Market Size and Forecast, By Application, 2016 – 2026, (US$ Mn)
• Market Size and Forecast, By Distribution Channel, 2016 – 2026, (US$ Mn)
• Market Size and Forecast, By Country, 2016 – 2026, (US$ Mn)
• China
• India
• Japan
• Australia
• South Korea
• ASEAN
• Rest of Asia Pacific
• Middle East
• Market Size and Forecast, By Drug Type, 2016 – 2026, (US$ Mn)
• Market Size and Forecast, By Application, 2016 – 2026, (US$ Mn)
• Market Size and Forecast, By Distribution Channel, 2016 – 2026, (US$ Mn)
• Market Size and Forecast, By Country/Region, 2016 – 2026, (US$ Mn)
• GCC
• Israel
• Rest of Middle East
• Africa
• Market Size and Forecast, By Drug Type, 2016 – 2026, (US$ Mn)
• Market Size and Forecast, By Application, 2016 – 2026, (US$ Mn)
• Market Size and Forecast, By Distribution Channel, 2016 – 2026, (US$ Mn)
• Market Size and Forecast, By Country/Region, 2016 – 2026, (US$ Mn)
• South Africa
• Central Africa
• North Africa
8. Competitive Landscape
• Company Profiles
9. Section
• References
• Research Methodology
• About us and Sales Contact

Have a Look at Related Research Insights:

Corona Virus Vaccine Market To Surpass US$ 73.2 Billion By 2027

DNA/Gene Microarray Market To Reach US$ 7,693.0 Million By 2027

DNA And RNA Sample Preparation Market To Surpass US$ 2,327.7 Million By 2027

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

To know more about us, please visit our website – www.coherentmarketinsights.com

Contact:

Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837